Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers.
暂无分享,去创建一个
J. Bertherat | X. Bertagna | G. Assié | F. Tissier | A. de Reyniès | E. Clauser | R. Libé | P. Launay | S. Gaujoux | B. Ragazzon | A. Fratticci
[1] P. Igaz,et al. Meta-analysis of adrenocortical tumour genomics data: novel pathogenic pathways revealed , 2010, Oncogene.
[2] J. Bertherat,et al. The pathophysiology, diagnosis and prognosis of adrenocortical tumors revisited by transcriptome analyses , 2010, Trends in Endocrinology & Metabolism.
[3] J. Bertherat,et al. Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development. , 2010, Human molecular genetics.
[4] J. Bertherat,et al. Pathogenesis of adrenocortical cancer. , 2009, Best practice & research. Clinical endocrinology & metabolism.
[5] Martin Fassnacht,et al. Clinical management of adrenocortical carcinoma. , 2009, Best practice & research. Clinical endocrinology & metabolism.
[6] Bertrand Dousset,et al. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Paul G. Gauger,et al. Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling , 2009, Clinical Cancer Research.
[8] J. Bertherat,et al. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors. , 2008, The Journal of clinical endocrinology and metabolism.
[9] G. Hammer,et al. Targeted disruption of β-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex , 2008, Development.
[10] I. Bourdeau,et al. Frequent mutations of β‐catenin gene in sporadic secreting adrenocortical adenomas * , 2007, Clinical endocrinology.
[11] J. Bertherat,et al. Adrenocortical cancer: pathophysiology and clinical management. , 2007, Endocrine-related cancer.
[12] C. Elie,et al. Somatic TP53 Mutations Are Relatively Rare among Adrenocortical Cancers with the Frequent 17p13 Loss of Heterozygosity , 2007, Clinical Cancer Research.
[13] J. Bertherat,et al. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. , 2005, Cancer research.
[14] S. Clark,et al. Mutation and methylation analysis of TP53 in adrenal carcinogenesis. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[15] F. Berger,et al. Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy. , 2005, The Journal of clinical endocrinology and metabolism.
[16] Paul G Gauger,et al. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. , 2003, The American journal of pathology.
[17] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] E. Baudin,et al. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. , 2001, Cancer research.
[19] G. Chrousos,et al. p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. , 1994, The Journal of clinical endocrinology and metabolism.
[20] P. Kleihues,et al. p53 Mutations in sporadic adrenocortical tumors , 1993, International journal of cancer.
[21] C. Elie,et al. Somatic TP 53 Mutations Are Relatively Rare among Adrenocortical Cancers with the Frequent 17 p 13 Loss of Heterozygosity , 2007 .